We are live on ! Find out more
PCM

Prelude Capital Management Portfolio holdings

AUM $1.31B
1-Year Est. Return 62.02%
This Fund
S&P 500
This Quarter Est. Return
+10.12%
1 Year Est. Return
+62.02%
3 Year Est. Return
+164.16%
5 Year Est. Return
+274.13%
10 Year Est. Return
+2,470.2%
AUM
$2.03B
AUM Growth
+$258M
Cap. Flow
+$193M
Cap. Flow %
9.48%
Top 10 Hldgs %
34.65%
Holding
2,402
New
679
Increased
420
Reduced
419
Closed
794

Top Buys

Rank Stock Value
1
APC
Anadarko Petroleum
APC
+$39.8M
2
AGN
Allergan plc
AGN
+$27.2M
3
BID
Sotheby's
BID
+$17.1M
4
VSM
Versum Materials, Inc.
VSM
+$16.5M
5
ARRY
Array Biopharma Inc
ARRY
+$15.8M

Top Sells

Rank Stock Value
1
TVPT
Travelport Worldwide Limited
TVPT
+$27.8M
2
ULTI
Ultimate Software Group Inc
ULTI
+$19M
3
CNC icon
Centene
CNC
+$15M
4
LXFT
Luxoft Holding, Inc.
LXFT
+$14.7M
5
NAVG
Navigators Group Inc
NAVG
+$10.9M

Sector Composition

Rank Sector Weight
1 Healthcare 7.64%
2 Technology 6.61%
3 Industrials 5.39%
4 Communication Services 5.27%
5 Consumer Discretionary 4.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BTU icon
1351
Peabody Energy
BTU
$2.87B
$12K ﹤0.01%
504
-878
-64% -$23.1K
CLLS
1352
Cellectis
CLLS
$271M
$12K ﹤0.01%
+770
New +$13.7K
DAN icon
1353
CALL
Dana Inc
DAN
$2.94B
$12K ﹤0.01%
+600
New +$10.7K
LUMN icon
1354
CALL
Lumen
LUMN
$6.09B
$12K ﹤0.01%
1,000
-4,700
-82% -$52.9K
SLB icon
1355
CALL
SLB Ltd
SLB
$76.5B
$12K ﹤0.01%
300
– –
XPO icon
1356
CALL
XPO
XPO
$23B
$12K ﹤0.01%
+578
New +$11.8K
ICPT
1357
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$12K ﹤0.01%
154
-20
-11% -$1.79K
OBSV
1358
DELISTED
ObsEva SA Ordinary Shares
OBSV
$12K ﹤0.01%
1,083
+793
+273% +$9.98K
TOWR
1359
DELISTED
Tower International, Inc.
TOWR
$12K ﹤0.01%
600
+497
+483% +$10.3K
AVAV icon
1360
AeroVironment
AVAV
$8.66B
$11K ﹤0.01%
200
+30
+18% +$1.98K
EML icon
1361
Eastern Company
EML
$151M
$11K ﹤0.01%
+400
New +$10.7K
OSBC icon
1362
Old Second Bancorp
OSBC
$1.31B
$11K ﹤0.01%
+830
New +$10.7K
RCKY icon
1363
Rocky Brands
RCKY
$372M
$11K ﹤0.01%
+400
New +$10.2K
UNFI icon
1364
United Natural Foods
UNFI
$2.9B
$11K ﹤0.01%
+1,270
New +$14.6K
SYRS
1365
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$11K ﹤0.01%
+119
New +$8.29K
DOOR
1366
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
$11K ﹤0.01%
+200
New +$10.3K
LBC
1367
DELISTED
Luther Burbank Corporation Common Stock
LBC
$11K ﹤0.01%
+996
New +$10.4K
CIR
1368
DELISTED
CIRCOR International, Inc
CIR
$11K ﹤0.01%
+236
New +$9.13K
CLVS
1369
DELISTED
Clovis Oncology, Inc.
CLVS
$11K ﹤0.01%
708
-2
-0.3% -$36
SAFM
1370
DELISTED
Sanderson Farms Inc
SAFM
$11K ﹤0.01%
+82
New +$11.6K
MGP
1371
DELISTED
MGM Growth Properties LLC Class A common shares representing limited liability company interests
MGP
$11K ﹤0.01%
350
+100
+40% +$3.17K
HTZ
1372
CALL
DELISTED
Hertz Global Holdings, Inc.
HTZ
$11K ﹤0.01%
+700
New +$10.5K
TIVO
1373
CALL
DELISTED
Tivo Inc
TIVO
$11K ﹤0.01%
1,500
+200
+15% +$1.61K
DNBF
1374
DELISTED
DNB Financial Corp
DNBF
$11K ﹤0.01%
+248
New +$10.2K
ANSS
1375
DELISTED
Ansys
ANSS
$10K ﹤0.01%
49
-88
-64% -$16.8K
53 54
55
56 57

Similar funds

PFBT
Parkside Financial Bank & Trust Saint Louis, Missouri $1.31B AUM 19.14% 1-Year Est. Return
CCP
Clarkston Capital Partners Rochester, Michigan $1.31B AUM 3.79% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
B
BloombergSen Toronto, Ontario, Canada $1.31B AUM 8.32% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return

Prelude Capital Management's Q2 2019 Portfolio in Review

As of Q2 2019, Prelude Capital Management held 2,402 positions worth $2.03B, up 15% from $1.77B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Prelude Capital Management deployed $193M of net new capital in Q2 2019, opening 679 new positions and adding to 420 existing holdings. Its largest new stake was Anadarko Petroleum: 593,600 shares worth $41.9M.

By sector, the portfolio is most concentrated in Healthcare at 7.6% of assets, up from 6.7% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Red Hat Inc, an estimated $8.6M trimmed.

  • Prelude Capital Management's largest Q2 2019 buy was Anadarko Petroleum: 593,600 shares worth $41.9M.
  • Prelude Capital Management added most to Allergan plc in Q2 2019, an estimated $27.2M increase.
  • Prelude Capital Management's biggest Q2 2019 reduction was Red Hat Inc, cutting an estimated $8.6M.
  • Prelude Capital Management fully exited Travelport Worldwide Limited in Q2 2019, selling an estimated $27.8M.
  • Prelude Capital Management's ten largest holdings make up 35% of its $2.03B portfolio in Q2 2019.
  • Prelude Capital Management opened 679 new positions and closed 794 in Q2 2019.
  • Prelude Capital Management's portfolio value rose 15% quarter-over-quarter to $2.03B.

Based on Prelude Capital Management's 13F filing for Q2 2019, filed 14 Aug 2019.